Could Lundbeck and Otsuka be looking to expand partnership?
Schizophrenia pills with microchips could be the next major area of collaboration between Lundbeck and Otsuka, who both see a huge potential in the technology.
by Benjamin Werner Christensen & Leonora Beck
Japanese pharma group Otsuka has come a long way with the development of pills containing microchips, so-called smart tablets, and Lundbeck could get in on the presumed success. It has yet to be decided if the Danish pharmaceutical company should play a part in next great drug hope from the Japanese group, but the CEO of the Danish firm, Ulf Wiinberg, is certainly open to the idea.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
